You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 1, 2024

Details for Patent: 10,821,277


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,821,277 protect, and when does it expire?

Patent 10,821,277 protects NEXPLANON and is included in one NDA.

This patent has fourteen patent family members in twelve countries.

Summary for Patent: 10,821,277
Title:Kit for and method of assembling an applicator for inserting an implant
Abstract: The invention pertains to a kit for assembling a disposable applicator for inserting an implant, in particular a rod-like implant containing an active substance, under the skin of a human or animal, the kit comprising a first component, in turn comprising a main housing part providing a handle for grasping and maneuvering the applicator, a cannula, and a cannula holder mounted in the main housing part, the main housing part having an opening which allows introduction of an implant into the proximal end of the cannula or the cannula holder, and, a second component for closing said opening, in turn comprising a second housing part and a rod attached to or forming an integral whole with the second housing part and mountable inside the cannula or the cannula holder.
Inventor(s): Beelen; Dennis Cornelis Franciscus (Oss, NL), Van Hermelen; Martin (Oss, NL), Moormann; Robertus Theodoor Maria (Oss, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL)
Assignee: MERCK SHARP & DOHME B.V. (Haarlem, NL)
Application Number:16/122,958
Patent Claim Types:
see list of patent claims
Delivery; Device;

Drugs Protected by US Patent 10,821,277

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 13, 2011 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,821,277

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
06100620Jan 19, 2006

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.